Celularity Inc. Deferred Income Tax Expense (Benefit)
Celularity Inc. (CELU) reported Deferred Income Tax Expense (Benefit) of $3.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2023-03-31
- Celularity Inc. deferred income tax expense (benefit) for the quarter ending 2021-12-31 was $1.36M, a 63.12% decline year-over-year.
- Celularity Inc. deferred income tax expense (benefit) for the quarter ending 2021-09-30 was -$1.36M.
- Celularity Inc. deferred income tax expense (benefit) for the quarter ending 2021-06-30 was $43.10K.
- Celularity Inc. deferred income tax expense (benefit) for the quarter ending 2021-03-31 was -$43.70K, a 147.54% decline year-over-year.
- Celularity Inc. deferred income tax expense (benefit) for fiscal 2021 was $3.00K.
- Celularity Inc. deferred income tax expense (benefit) for fiscal 2020 was -$4.72M.
- Celularity Inc. deferred income tax expense (benefit) for fiscal 2019 was -$1.65K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 9 month as first filed | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|
| 2021-12-31 | $1.36M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $3.60K derived: sum of 2 quarters · filed 2023-03-31 | $46.70K derived: sum of 3 quarters · filed 2023-03-31 | $3.00K 10-K · filed 2023-03-31 | ||
| 2021-09-30 | -$1.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.31M derived: sum of 2 quarters · filed 2021-11-12 | -$1.36M 10-Q · filed 2021-11-12 | $2.33M derived: sum of 4 quarters · filed 2022-03-31 | ||
| 2021-06-30 | $43.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-19 | -$602.00 10-Q · filed 2021-08-19 | $3.68M derived: sum of 3 quarters · filed 2022-03-31 | -$4.71M derived: sum of 4 quarters · filed 2022-03-31 | ||
| 2021-03-31 | -$43.70K 10-Q · filed 2021-05-24 | $3.64M derived: sum of 2 quarters · filed 2022-03-31 | -$4.75M derived: sum of 3 quarters · filed 2022-03-31 | -$4.85M derived: sum of 4 quarters · filed 2022-03-31 | ||
| 2020-12-31 | $3.69M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$4.71M derived: sum of 2 quarters · filed 2022-03-31 | -$4.81M derived: sum of 3 quarters · filed 2022-03-31 | -$4.72M 10-K · filed 2022-03-31 | $2.25K 10-K · filed 2021-03-04 | |
| 2020-09-30 | -$8.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$8.49M derived: sum of 2 quarters · filed 2021-11-12 | -$8.40M 10-Q · filed 2021-11-12 | $5.53K 10-Q · filed 2020-11-16 | -$8.44M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | -$99.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-19 | -$7.08K 10-Q · filed 2021-08-19 | -$48.20K derived: sum of 3 quarters · filed 2021-08-19 | -$60.52K derived: sum of 4 quarters · filed 2021-08-19 | ||
| 2020-03-31 | $91.93K 10-Q · filed 2021-05-24 | $50.81K derived: sum of 2 quarters · filed 2021-05-24 | $38.49K derived: sum of 3 quarters · filed 2021-05-24 | |||
| 2019-12-31 | -$41.12K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | -$53.44K derived: sum of 2 quarters · filed 2021-05-24 | -$1.65K 10-K/A · filed 2021-05-24 | |||
| 2019-09-30 | -$12.32K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $39.47K 10-Q · filed 2020-11-16 | ||||
| 2019-06-30 | $51.78K 10-Q · filed 2020-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |